Health Headlines - February 18

home   >   blogdigger

Merck May Consider Selling Vioxx Again Merck & Co. Inc. (MRK.N) will consider selling its arthritis pill Vioxx again if the U.S. Food and Drug Administration decides the cardiovascular risks are similar to those of related prescription pain relievers, a company official said on Thursday. Alzheimer-Risk Gene Makes Brain Work Harder Mental tasks take an extra effort for healthy non-demented older adults with a genetic variation called APOE-e4, which has been linked to an increased risk of develop ... (more)  

- link to Health Headlines - February 18 -
Last update: 05/26/2005

Recommended Reading

    GAD patients often require combined therapy.(Practical Psychopharmacology)(generalized anxiety disorder ) : An article from: Clinical Psychiatry News
    Vamos Mxico: transparencia y experiencia comparada.(supuestos actos ilcitos en operaciones de organizacin) : An article from: Proceso
    Zyprexa - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
    Zyprexa PAI forces Lilly's hand on media fill issues.(performance audit inspection on Eli Lilly and Co.) : An article from: Validation Times
    Entre actos: dielogos sobre teatro espanol entre siglos.(TT: Entre actos: dialogos sobre teatro espanol entre siglos.)(Resea) : An article from: Anales de la Literatura Espaola Contempornea
    Zoloft - A Medical Dictionary Bibliography and Annotated Research Guide to Internet References
    Panel Revisits Safety Data on COX-2 Drug Labels.(Brief Article) : An article from: Family Practice News
    Head-to-head comparison of osteoporosis drugs: alendronate vs. raloxifene.(Women's Health) : An article from: Family Practice News